Glenmark Pharma to study potential Covid-19 drug combination

The study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it would conduct clinical trials in India of just favipiravir as a potential treatment for Covid-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ac2jMo
via IFTTT